Introduction

Just the Intersection of Opioids and Illicit Stimulants Part 2

Just the Intersection of Opioids and Illicit Stimulants Part 2

Original Release Date: January 29, 2021

This week, in episode two of our 2021 Illicit Substance Use Response season Just Science continues the conversation with Dr. Jon Zibbell as he discusses the American history of drug epidemics, what we can learn from past stimulant crises, and the importance of tailoring interventions in this episode of Just Science. 

This season is in collaboration with the Bureau of Justice Assistance Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) funding to respond to illicit substance use and misuse in order to reduce overdose deaths, promote public safety, and support access to services.

This episode of Just Science is funded by the National Institute of Justice’s Forensic Technology Center of Excellence [Award 2016-MU-BX-K110].

Listen to or download the episode here:

View or download the episode transcript here:
Transcript



Guest Biography

Jon E. Zibbell, Ph.D., conducts behavioral and community-based epidemiological research on risk factors and health outcomes associated with the opioid epidemic and injection drug use. He is a medical anthropologist with two decades of field experience in the areas of injection drug use, opioid use disorder, drug overdose, and injection-related infectious disease. Previously, Dr. Zibbell worked as a CDC health scientist in the Divisions of Viral Hepatitis and Unintentional Injury Prevention, conducting epidemiological and surveillance research on viral hepatitis and drug overdose while assisting states during outbreak investigations to respond to injuries and infections caused by drug use behaviors. In addition to research, he has conducted rapid ethnographic needs assessments for community-based syringe service and overdose prevention programs and continues to assist states and community organizations to develop evidence-based approaches to reduce morbidity and mortality associated with the opioid epidemic. Dr. Zibbell’s work has appeared in both academic and professional journals and he holds a joint adjunct appointment in the Center for the Study of Human Health and the Department of Anthropology at Emory University. View RTI Profile here.


Related Content

Evaluating a Statistical Method for Comparison of Mass Spectra of Novel Psychoactive Substance

← Back to Webinar Series Page This webinar originally occurred on July 25, 2024 Duration: 1 hour Overview Identification of novel psychoactive substances (NPS) based on comparisons of electron-ionization (EI) mass spectra continues to pose challenges in seized drug analysis.…

LC-DAD with Optional ESI/MS: An Emerging Gold Standard for Hemp Compliance Testing

← Back to Webinar Series Page This webinar originally occurred on June 13, 2024 Duration: 1 hour Overview Hemp compliance testing is used to quantify total Δ9-tetrahydrocannabinol (Δ9-THC), including both Δ9-THC and its precursor, i.e., Δ9-tetrahydrocannabinolic acid (Δ9-THCA), to determine…